PHS
PFM Health Sciences Portfolio holdings
AUM
$950M
1-Year Est. Return
57.92%
This Fund
S&P 500
1 Year Est. Return
+57.92%
AUM
$950M
AUM Growth
-$37.5M
(-3.8%)
Holding
97
Top Buys
| 1 | +$22.3M | |
| 2 | +$15.9M | |
| 3 | +$12.9M | |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$12.8M |
| 5 |
Merit Medical Systems
MMSI
|
+$12.7M |
Top Sells
| 1 | +$23.2M | |
| 2 | +$20.5M | |
| 3 | +$19.8M | |
| 4 |
Centene
CNC
|
+$18.9M |
| 5 |
United Therapeutics
UTHR
|
+$13.9M |
Sector Composition
| 1 | Healthcare | 98.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Rezolute
RZLT
$409M
| $393K | 0.04% |
128,726
-77,539
|
|
||
77
ADMA Biologics
ADMA
$1.85B
| – | – |
-1,270,894
|
|
||
78
Align Technology
ALGN
$12B
| – | – |
-42,304
|
|
||
79
CVS Health
CVS
$122B
| – | – |
-107,767
|
|
||
80
Elanco Animal Health
ELAN
$11.8B
| – | – |
-207,311
|
|
||
81
Fortrea Holdings
FTRE
$1.52B
| – | – |
-165,439
|
|
||
82
Gilead Sciences
GILD
$160B
| – | – |
-71,018
|
|
||
83
IQVIA
IQV
$30.6B
| – | – |
-37,852
|
|
||
84
Disc Medicine
IRON
$2.56B
| – | – |
-11,002
|
|
||
85
Intuitive Surgical
ISRG
$149B
| – | – |
-15,410
|
|
||
86
Medtronic
MDT
$105B
| – | – |
-213,796
|
|
||
87
Molina Healthcare
MOH
$9.94B
| – | – |
-22,802
|
|
||
88
Merck
MRK
$298B
| – | – |
-187,834
|
|
||
89
Neuropace
NPCE
$537M
| – | – |
-11,329
|
|
||
90
Sanofi
SNY
$108B
| – | – |
-176,413
|
|
||
91
Teleflex
TFX
$5.75B
| – | – |
-102,395
|
|
||
92
Treace Medical Concepts
TMCI
$228M
| – | – |
-50,000
|
|
||
93
Universal Health Services
UHS
$8.79B
| – | – |
-57,409
|
|
||
94
Veeva Systems
VEEV
$28.2B
| – | – |
-32,489
|
|
||
95
State Street SPDR S&P Biotech ETF
XBI
$7.83B
| – | – |
0
|
|
||
96
State Street Health Care Select Sector SPDR ETF
XLV
$39.2B
| – | – |
0
|
|